To explore the impact of different PTEN statuses on the immunological classification of gliomas, glioma cells were separated into PTEN deletion, PTEN mutation, PTEN wild type, and PTEN wild type-shPTEN groups for in-vitro experiments. This evidence concerns the gene PTEN and central nervous system cancer.